SHAREHOLDER ALERT: SAVA HYRE WDH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines - Yahoo Finance
NEW YORK, NY / ACCESSWIRE / September 27, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Cassava Sciences, Inc. (NASDAQ:SAVA)
If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/cassava-sciences-inc-loss-submission-form?prid=19880&wire=1
Lead Plaintiff Deadline: October 26, 2021
Class Period: February 2, 2021 - August 24, 2021
Allegations against SAVA include that: (a) the quality and integrity of the scientific data supporting Cassava's claims for simufilam's, a small molecule drug designed to treat Alzheimer's disease, efficacy had been overstated; (b) the scientific data supporting Cassava's claims for simufilam's efficacy were biased; and (c) as a result of the foregoing, Defendants' positive statements during the Class Period about the Company's business metrics and financial prospects and the likelihood of Food and Drug Administration approval were false and misleading and/or lacked a reasonable basis.
HyreCar Inc. (NASDAQ:HYRE)
If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/hyrecar-inc-loss-submission-form?prid=19880&wire=1
Lead Plaintiff Deadline: October 26, 2021
Class Period: May 14, 2021 - August 10, 2021
Allegations against HYRE include that: (a) HyreCar had materially understated its insurance reserves; (b) HyreCar had systematically failed to pay valid insurance claims incurred prior to the Class Period; (c) HyreCar had incurred significant expenses transitioning to its new third-party insurance claims administrator and processing claims incurred from prior periods; (d) HyreCar had failed to appropriately price risk in its insurance products and was experiencing elevated claims incidence as a result; (e) HyreCar had been forced to dramatically reform its claims underwriting, policies and procedures in response to unacceptably high claims severity and customer complaints; and (f) as a result, HyreCar's operations and prospects were misrepresented because the Company was not on track to meet the financial estimates provided to investors during the Class Period, and such estimates lacked a reasonable basis in fact, including HyreCar's purported gross margin, EBITDA (earnings before interest, taxes, depreciation, and amortization), and net loss trajectories.
source: https://finance.yahoo.com/news/shareholder-alert-sava-hyre-wdh-094000810.html
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.